Biocomputing drug repurposing toward targeted therapies

por Cardone, Luca
Publicado 2016

Boosting the arsenal against COVID-19 through computational drug repurposing

por Ciliberto, Gennaro, Cardone, Luca
Publicado 2020

Beyond the Genomic Mutation: Rethinking the Molecular Biomarkers of K-RAS Dependency in Pancreatic Cancers

por Mottini, Carla, Cardone, Luca
Publicado 2020

Activation of β-Catenin by Oncogenic PIK3CA and EGFR Promotes Resistance to Glucose Deprivation by Inducing a Strong Antioxidant Response

por Cardone, Luca, Bardelli, Alberto, Avvedimento, Vittorio Enrico
Publicado 2012

Differential network analysis for the identification of condition-specific pathway activity and regulation

por Gambardella, Gennaro, Moretti, Maria Nicoletta, de Cegli, Rossella, Cardone, Luca, Peron, Adriano, di Bernardo, Diego
Publicado 2013

Drug repurposing for the treatment of glioblastoma multiforme

por Abbruzzese, Claudia, Matteoni, Silvia, Signore, Michele, Cardone, Luca, Nath, Kavindra, Glickson, Jerry D., Paggi, Marco G.
Publicado 2017

PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer

por Liedtke, Cornelia, Cardone, Luca, Tordai, Attila, Yan, Kai, Gomez, Henry L, Figureoa, Luis J Barajas, Hubbard, Rebekah E, Valero, Vicente, Souchon, Eduardo A, Symmans, W Fraser, Hortobagyi, Gabriel N, Bardelli, Alberto, Pusztai, Lajos
Publicado 2008

Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds

por Carrella, Diego, Manni, Isabella, Tumaini, Barbara, Dattilo, Rosanna, Papaccio, Federica, Mutarelli, Margherita, Sirci, Francesco, Amoreo, Carla A., Mottolese, Marcella, Iezzi, Manuela, Ciolli, Laura, Aria, Valentina, Bosotti, Roberta, Isacchi, Antonella, Loreni, Fabrizio, Bardelli, Alberto, Avvedimento, Vittorio E., di Bernardo, Diego, Cardone, Luca
Publicado 2016